Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Report Date: October 28, 2021
Reporting Period: Quarter ended September 30, 2021
This filing announces the financial results for the third quarter of fiscal year 2021. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text serves as a cover document referencing the results but does not contain specific numerical data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to Exhibit 99.1 for these figures.
Material Changes
No specific material changes versus the prior comparable period are detailed in this text. The document solely confirms the announcement of the quarter's results.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Guidance and Risks: No specific guidance, outlook, risks, contingencies, or unusual items are described in the text of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and earnings per share figures.
- Verify year-over-year growth rates and segment performance details not included in this summary.
- Check for any forward-looking guidance or updated fiscal year estimates in the attached press release.
- Confirm the impact of foreign currency fluctuations or supply chain issues if mentioned in the full press release.